Dave Helsel - Jul 14, 2021 Form 4/A - Amendment Insider Report for ANGIODYNAMICS INC (ANGO)

Role
SVP Global Operations and R&D
Signature
/s/ Richard C. Rosenzweig, Attorney in Fact
Stock symbol
ANGO
Transactions as of
Jul 14, 2021
Transactions value $
$0
Form type
4/A - Amendment
Date filed
12/30/2021, 05:01 PM
Date Of Original Report
Jul 23, 2021
Next filing
Aug 18, 2021

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ANGO Non-Qualified Stock Option (right to buy) Award $0 +11K $0.00 11K Jul 21, 2021 Common Stock 11K $26.49 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On July 23, 2021, the reporting person filed a Form 4 to report, among other items, the granting of stock options of AngioDynamics, Inc., which contained an administrative error as to the exercise price of such options.
F2 These stock options vest in four equal annual installments beginning on July 21, 2022, such that 25% of the options will vest on each of July 21, 2022, 2023, 2024 and 2025.